Siga Technologies (SIGA) Cash from Investing Activities Growth (5y) (2015 - 2025)
Siga Technologies (SIGA) Cash from Investing Activities Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Siga Technologies | 223.05 Mn | 68.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -9.94% |
| Dec 31, 2024 | -516.68% |
| Sep 30, 2024 | -2.17% |
| Jun 30, 2024 | -273.86% |
| Jun 30, 2023 | 4.89% |
| Dec 31, 2021 | -15.12% |
| Jun 30, 2021 | -33.50% |
| Mar 31, 2021 | -10.12% |
| Mar 31, 2020 | -14.91% |
| Dec 31, 2019 | 75.25% |
| Sep 30, 2019 | 65.23% |
| Jun 30, 2019 | -91.05% |
| Mar 31, 2019 | 8.80% |
| Dec 31, 2018 | 206.93% |
| Jun 30, 2018 | 20.89% |
| Dec 31, 2017 | 32.39% |
| Sep 30, 2017 | 3.97% |
| Jun 30, 2017 | 51.12% |
| Dec 31, 2016 | 61.15% |
| Sep 30, 2016 | -96.02% |